TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

The current price of 600329 is 33.12 CNY — it has increased by 0.03% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stocks are traded under the ticker 600329.

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.

600329 stock is 2.54% volatile and has beta coefficient of 1.16. Check out the list of the most volatile stocks — is TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED there?

One year price forecast for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED has a max estimate of 45.80 CNY and a min estimate of 45.80 CNY.

Yes, you can track TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED financials in yearly and quarterly reports right on TradingView.

600329 stock has risen by 7.01% compared to the previous week, the month change is a 12.65% rise, over the last year TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED has showed a 15.94% decrease.

600329 net income for the last quarter is ‪128.52 M‬ CNY, while the quarter before that showed ‪135.70 M‬ CNY of net income which accounts for −5.29% change. Track more TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED financial stats to get the full picture.

Yes, 600329 dividends are paid annually. The last dividend per share was 1.12 CNY. As of today, Dividend Yield (TTM)% is 3.38%. Tracking TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED dividends might help you take more informed decisions.

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED dividend yield was 3.80% in 2023, and payout ratio reached 99.74%. The year before the numbers were 3.85% and 99.93% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 600329 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock right from TradingView charts — choose your broker and connect to your account.

600329 reached its all-time high on May 29, 2023 with the price of 56.26 CNY, and its all-time low was 1.60 CNY and was reached on Jul 18, 2005.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has ‪4.62 K‬ employees. See our rating of the largest employees — is TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock shows the buy signal. See more of TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED future price: according to them, 600329 price has a max estimate of 45.80 CNY and a min estimate of 45.80 CNY. Read a more detailed TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED forecast: see what analysts think of TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED EBITDA is ‪884.48 M‬ CNY, and current EBITDA margin is 10.96%. See more stats in TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED financial statements.